Lymphoma Drug SGN-35 – The Nebraska Medical Center

Posted: October 2, 2011 at 9:16 pm

This post was added by Dr. Richardson



"This is really a breakthrough in that we finally have something to treat these really difficult to treat patients." The FDA approved SGN-35 as a treatment for Hodgkin's Lymphoma in August 2011. It is the first FDA-approved Hodgkin's treatment since 1977

Originally posted here:
Lymphoma Drug SGN-35 - The Nebraska Medical Center

Related Post
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.